Peripheral Vascular Devices Market (2025 to 2035)

Peripheral Vascular Devices Market

The global Peripheral Vascular Devices Market is projected to register significant growth during the forecast period of 2025-2035. The growth of the market is attributed to the increasing prevalence of peripheral artery disease (PAD), rise in the incidence of diabetes, hypertension, obesity, and other cardiovascular disorders, and increasing aging population are more vulnerable to vascular complications. Market growth is also fuelled by the rising adoption of minimally invasive endovascular procedures and continuous technological innovations in angioplasty balloons, stents, atherectomy devices, and thrombectomy systems. The market is expected to grow from an estimated USD 1,080 million in 2025 to USD 1,955 million by 2035, at a CAGR of 5.2% during 2026-2035.

Peripheral Vascular Devices Market Revenue Forecast, 2022–2035 (US$ Million)

Key Market Highlights & Insights

• North America is expected to dominate the global Peripheral Vascular Devices Market in terms of share during the forecast period due to high prevalence of peripheral artery disease (PAD), advanced healthcare infrastructure, favourable reimbursement policies, and high adoption of minimally invasive vascular interventions.
• Asia Pacific is expected to grow at the highest CAGR of 6.39% during the forecast period due to the increasing prevalence of diabetes and cardiovascular diseases, improving healthcare access, increasing awareness regarding vascular disorders, and increasing investments in interventional cardiology and vascular surgery services.
• Angioplasty balloons are expected to be the leading segment by product type, accounting for a share of roughly 19.00% in 2025, owing to their extensive use in endovascular procedures to treat peripheral artery disease and vessel stenosis.
• The largest segment is peripheral artery disease (PAD) based on application, holding approximately 34.00% market share altogether, followed by venous diseases, aneurysms and thrombotic occlusions.
• Fast-growing drug-coated balloons, drug-eluting stents and intravascular imaging technologies with a projected CAGR of 14.00% over 2026–2035 driven by technological advancements, better clinical outcomes and rising physician preference for minimally invasive treatment approaches

Market Intelligence Overview (Past, Present and Forecast):

• 2025 Peripheral Vascular Devices Market Size: USD 1,080 Million
• Peripheral Vascular Devices Market Size in 2035: USD 1,955 Million
• Peripheral Vascular Devices Market Size CAGR (2026-2035): 5.2%

The growth is largely attributed to the increasing global burden of peripheral artery disease, increasing prevalence of diabetes and obesity, increasing preference for minimally invasive vascular interventions, and continuing developments in angioplasty balloons, stents, atherectomy devices, thrombectomy systems, and intravascular imaging technologies. Increasing healthcare infrastructure and awareness about early diagnosis and treatment of vascular diseases are further supporting the global market expansion.

Epidemiological Evaluation of Disease (Condition):

• Trends in prevalence & incidence of peripheral artery disease (PAD), deep vein thrombosis (DVT), chronic venous disorders, and other peripheral vascular diseases
• Patient population analysis in adult and geriatric populations
• Demographic burden of diabetes, hypertension, obesity, smoking and cardiovascular diseases
• Peripheral vascular disease burden distribution by geography 

Treatment Landscape Summary:

• Standard of care analysis: peripheral vascular disease management
• Current treatment modalities including endovascular, surgical and pharmacological interventions
• Unmet clinical needs in early diagnosis, access to treatment and long-term management of the disease
• Role of angioplasty, stenting, atherectomy, thrombectomy and vascular imaging-guided interventions in comparative treatment

Peripheral Vascular Devices Market Outlook Analysis Conservative, Likely, Optimistic, (US$ Million), 2025–2035

Market Dynamics:

Market Drivers:

Increasing Worldwide Burden of Cardiovascular Disorders and Peripheral Artery Disease

Demand for peripheral vascular devices is significantly driven by the increasing prevalence of peripheral artery disease (PAD) and other cardiovascular disorders. Peripheral vascular devices are increasingly used in minimally invasive diagnostic and therapeutic interventions for restoring blood flow, preventing disease progression, and reducing risk of limb loss. Peripheral vascular devices, including angioplasty balloons, stents, atherectomy systems, thrombectomy devices, and vascular imaging technologies, are integral to the treatment of PAD and other vascular diseases. The increase in number of peripheral vascular procedures performed worldwide has been significant due to increasing incidences of diabetes, hypertension, obesity and vascular diseases associated with smoking. According to global health estimates, PAD affects more than million people worldwide. Cardiovascular diseases account for approximately million deaths annually and remain among the leading causes of morbidity and mortality worldwide. The growing burden of vascular disease continues to fuel the use of advanced peripheral vascular interventions.

The Future Burden of Vascular Disease and a Growing Older Population

The future burden of vascular diseases is anticipated to increase, and this is encouraging hospitals, ambulatory surgical centres, and specialty vascular clinics to use peripheral vascular devices. Worldwide projections suggest that the number of affected people will reach million by 2050 due to an aging population, the rising prevalence of diabetes, sedentary lifestyles and the increase in cardiovascular risk factors. Moreover, the worldwide population aged 60 years and above is projected to rise substantially, which will in turn increase the number of patients at risk for PAD, chronic limb-threatening ischemia, and other vascular-related complications. The growing demand for minimally invasive endovascular procedures coupled with continuous technological improvements in drug-coated balloons, drug-eluting stents and intravascular imaging systems are expected to further boost the market growth in developed and emerging regions.

Market Restraint:

Cost of Peripheral Vascular Procedures and Advanced Devices High

High cost of advanced endovascular procedures and vascular intervention technologies is a challenging factor for the peripheral vascular devices market. The use of drug-coated balloons, drug-eluting stents, atherectomy systems, thrombectomy devices, embolic protection systems and intravascular imaging platforms requires significant investment in specialized equipment, trained healthcare professionals and advanced healthcare infrastructure. Moreover, hospitals and health care providers have to pay for patient training, procedural expertise and post-procedure patient management, which all add to the overall cost of treatment. Such costs may limit access to advanced vascular interventions, especially in cost sensitive and developing health care markets.

Strict regulatory requirements and clinical evidence standards

In addition, peripheral vascular devices are also subject to stringent regulatory approval and clinical evidence requirements to ensure long-term safety and efficacy. Manufacturers also face extensive requirements for clinical trials, quality management and post-market surveillance from regulatory authorities. Lengthening product development timelines and costs to demonstrate long-term patency rates, reduced restenosis risk and improved patient outcomes. Such regulatory and compliance hurdles can delay product launches and increase operational costs and limit the adoption of innovative vascular technologies in some markets.

Market Opportunities:

Minimally Invasive Endovascular Technologies Adoption on the Rise

Further, the increasing adoption of drug-coated technologies, image-guided interventions and next-generation vascular devices is also resulting in significant market opportunities. Technological advances are improving the procedural accuracy, reducing the restenosis rates and improving the long-term patency of the vessels. In addition, rising awareness about peripheral artery disease, increasing screening programs, expanding healthcare infrastructure in emerging economies and growing investments in cardiovascular care are expected to fuel long-term market growth.

Increasing adoption of minimally invasive endovascular procedures is creating huge growth opportunities in the peripheral vascular devices market. Healthcare providers are increasingly adopting advanced angioplasty balloons, stents, atherectomy systems, thrombectomy devices and intravascular imaging technologies to improve treatment outcomes and reduce recovery time while minimizing procedural risks. The trend towards less invasive approaches to treatment is driving the adoption of peripheral vascular devices across hospitals, ambulatory surgical centres and specialty vascular clinics globally. on early diagnosis and outpatient vascular interventions is also anticipated to drive the demand for advanced peripheral vascular devices in developed and emerging regions.

Peripheral Vascular Devices Market Share Analysis By Segments, 2025 (%)

Key Players Market Share of Peripheral Vascular Devices

By Type of Product:

Angioplasty Balloons to Capture 21% Share in 2025, Leading the Market Due to Extensive Application in Treatment of Peripheral Artery Disease (PAD) & Endovascular Procedures. The fastest-growing segment is Drug-Coated Balloons (DCBs) (~8.5% CAGR) with the ability to reduce restenosis rates and improve long-term vessel patency. “Stents and atherectomy devices are still being adopted at a good pace.

• Balloons for Angioplasty
• Drug Coated Balloons (DCB’s)
• Stent periferico
• Athéctomie devices
• Devices for thrombectomy
• Guide wires
• Catheters
• IVC (Inferior Vena Cava) Filters
• Hemodynamic flow altering devices
• Other

By Application:

Peripheral Artery Disease (PAD) also holds the largest market share (~34%) which is due to the rising prevalence of diabetes, smoking-related vascular disease and aging populations. Deep Vein Thrombosis (DVT) and Venous Diseases are the fastest growing segments (~8.0% CAGR) due to increasing awareness, better diagnosis and broadening treatment options.

• Peripheral arterial disease (PAD)
• Deep Venous Thrombosis (DVT)
• Chronic Venous Insufficiency
• Pulmonary Embolism
• Aneurisms
• Critical Limb Ischemia
• Management of Arteriovenous Fistulaa
• Other

By User Type:

Hospitals have a ~43% share due to high procedural volumes, advanced vascular intervention capabilities and availability of specialized healthcare professionals. The fastest growing segment (~7.8% CAGR) is Ambulatory Surgical centres (ASCs), driven by the increasing preference for minimally invasive outpatient procedures and lower treatment costs. Specialty vascular clinics continue to grow robustly.

• Health care facilities
• Ambulatory Surgical centres (ASC’s)
• Vascular Specialty Clinics
• Cath Labs
• Imaging Centres
• Others. By Technology: Conventional Endovascular Devices (~58% market share) have a proven track record in clinical use and are widely available. Drug-Eluting and Drug-Coated Technologies is the fastest growing segment (~8.8% CAGR) because of better clinical outcomes and lower rates of restenosis.
• Conventional Endovascular Devices
• Technologies coated with drugs
• Drug release technologies
• Intra Vascular Imaging Technologies
• Technologies for Mechanical Thrombectomy
• Other

Regional Market Insights:

Peripheral Vascular Devices Market Regional Share Analysis and Forecast, 2022–2025–2032

North America Peripheral Vascular Devices Market:

North America dominated the global Peripheral Vascular Devices Market and accounted for approximately 42.50% share in 2025, worth around USD 2,856 million. The regional market is mainly driven by the high prevalence of peripheral artery disease (PAD), advanced healthcare infrastructure, favourable reimbursement policies, and rapid adoption of minimally invasive endovascular procedures. Further, the high number of leading medical device manufacturers and ongoing technological advances in vascular intervention devices are other factors supporting the market growth.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 North America Peripheral Vascular Devices Industry Revenue: USD 2,856 Million
• Market Size & Share North America Peripheral Vascular Devices Industry: USD 4,412 Million,2035
• North America Peripheral Vascular Devices Market CAGR (2026-2035): 3.05%

Drivers

• High rates of diabetes, cardiovascular disease and peripheral artery disease
• Increased use of minimally invasive, endovascular procedures
• Advanced healthcare and vascular intervention infrastructure available
• Ongoing technological advances in stents, angioplasty balloons and atherectomy devices

Restraints

• Expensive, high-tech vascular intervention procedures
• Stringent regulatory approval process for medical devices
• Risk of procedure related complications and re-stenosis
• Limited access to advanced vascular care in some remote areas

Opportunities

• Increasing use of drug-coated balloons and drug-eluting stents
• Development of vascular intervention centers for outpatients and ambulatory patients
• Greater use of intravascular imaging and image-guided procedures

United States Peripheral Vascular Devices Market:

The United States was the largest contributor to the North America Peripheral Vascular Devices Market in terms of share. It contributed to approximately 87.00% of the regional market in 2025. The U.S. market was valued at almost USD 2,487 million, supported by a high burden of peripheral artery disease, favorable reimbursement frameworks, advanced vascular care infrastructure, and widespread adoption of innovative endovascular technologies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• United States Peripheral Vascular Devices Market Size by 2025: USD 2,487 Million
• United States Peripheral Vascular Devices Market Revenue, 2035: USD 3,750 Million
• United States Peripheral Vascular Devices Market, CAGR (2026-2035) – 4.20%

Drivers

• Peripheral artery disease and vascular complications in diabetes are common
• High rates of adoption of advanced endovascular and minimally invasive procedures
• Large spending on healthcare and investment in cardiovascular care Manufacturers of leading peripheral vascular devices and innovation centres showcase

Restraints

• Costs of procedures and devices for vascular interventions are high
• Stringent regulatory and post-market surveillance mandates
• Risk of re-interventions from restenosis and disease progression
• Inequities in healthcare influencing access to specialized vascular care

Opportunities

• Growing uptake of drug-coated balloons, thrombectomy and atherectomy technologies
• More outpatient surgical centers performing vascular procedures
• Increasing adoption of next-generation vascular intervention technologies and AI-driven imaging

Canada Peripheral Vascular Devices Market:

In 2025, Canada held the second largest share of the North American Peripheral Vascular Devices Market, valued at approximately USD 371.3 million. The market is growing steadily due to increasing prevalence of peripheral artery disease (PAD), rising demand for minimally invasive vascular interventions, growing healthcare investments and expanding adoption of advanced angioplasty balloons, stents, atherectomy devices and thrombectomy systems across hospitals and specialty vascular centers.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Canada Peripheral Vascular Devices Market Size, 2025: USD 371 Million
• 2035 Canada Market Size for Peripheral Vascular Devices: USD 661 Million
• Canada Peripheral Vascular Devices CAGR (2026-2035): 5.95%

Drivers

• Over 800,000 Canadians living with peripheral artery disease and growing demand for vascular interventions
• Increasing use of minimally invasive endovascular procedures for the treatment of arterial and venous diseases
• Higher expenditure on healthcare and investments in programs for management of cardiovascular disease
• Increased use of drug-coated balloons, drug-eluting stents and newer thrombectomy technologies for better patient outcomes

Restraints

• Costly advanced peripheral vascular devices and interventional procedures
• Limited access to specialized vascular care in rural and remote areas
• Tight regulatory requirements for device approval and commercialisation
• Reimbursement issues associated with novel vascular technologies

Opportunities

• Outpatient vascular intervention centers and development of ambulatory surgical facilities
• Increase in the adoption of AI-enabled imaging, navigation and procedural planning technologies
• Growing demand for next generation bioresorbable scaffolds and drug coated device platforms

Europe Peripheral Vascular Devices Market

In 2025, Europe accounted for about 27.50% share of the global Peripheral Vascular Devices Market and was valued at close to USD 1,848 million. Some of the key factors benefitting the market include high prevalence of cardiovascular and peripheral vascular diseases, well-established healthcare infrastructure, increasing adoption of minimally invasive vascular procedures, and strong demand for advanced endovascular treatment technologies in major European countries.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Europe Peripheral Vascular Devices Market Size: USD 1,848 Million
• 2035 Europe Peripheral Vascular Devices Market Size, USD 2,960 Million
• Europe Peripheral Vascular Devices CAGR (2026-2035): 3.33%

Drivers

• Peripheral arterial disease affects an estimated 40 million-plus people in Europe and is driving demand for vascular interventions
• Robust adoption of angioplasty balloons, peripheral stents, thrombectomy devices and atherectomy systems
• Growing aging population prone to vascular diseases and circulation disorders
• Strong health care infrastructure and increasing investments in cardiovascular disease management

Restraints

• European Medical Device Regulation (EU MDR) regulatory requirements are demanding
• Advanced vascular interventions with high procedural and device costs
• Unequal access to specialist facilities for vascular treatment
• Budgetary pressures on public healthcare systems impact procurement of premium devices

Opportunities

• Use of drug-coated balloon and drug-eluting stents for peripheral interventions
• Increasing adoption of AI-based vascular imaging, diagnostics and procedural guidance technologies
• Growing investments in next-generation bioresorbable vascular scaffolds and minimally invasive treatment platforms

United Kingdom Peripheral Vascular Devices Market:

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 United Kingdom Peripheral Vascular Devices Market Size: USD 295.7 Million
• 2035 United Kingdom Peripheral Vascular Devices Market size is USD 444 Million
• United Kingdom Peripheral Vascular Devices CAGR (2026-2035) : 4.15%

The United Kingdom held 16.00% of the European Peripheral Vascular Devices Market in 2025, with a value of nearly USD 295.7 million. The market growth is driven by the robust public healthcare system under the NHS, the increasing prevalence of peripheral artery disease (PAD), the rising demand for minimally invasive vascular interventions, and the rising adoption of advanced peripheral stents, drug-coated balloons, atherectomy devices, and thrombectomy systems.

Drivers

• Over 7 million people in the UK suffer from cardiovascular and circulatory diseases with increasing demand for vascular interventions
• Developing interest in early diagnosis and treatment of peripheral artery disease via NHS vascular programs
• Increasing use of minimally invasive endovascular procedures for arterial and venous conditions
• Implementation of NHS supported cardiovascular care programmes and advanced vascular treatment pathways

Restraints

• NHS budgetary constraints on the purchase of premium vascular devices
• Some areas experience long wait times for elective vascular procedures
• Regional variation in access to centres of specialised vascular intervention
• Challenging regulations and procurement processes for new devices

Opportunities

• Development of outpatient vascular care and ambulatory interventional centers
• Increased uptake of AI-enabled vascular imaging and procedure guidance technologies
• Increased use of drug coated balloons, bioresorbable scaffolds and next generation peripheral stent platforms

Germany Peripheral Vascular Devices Market:

In 2025, the European Peripheral Vascular Devices market was valued at approximately USD 369 million and captured around 20.00% of Germany. The market growth is expected to be further driven by advanced healthcare infrastructure, high burden of cardiovascular diseases, strong adoption of minimally invasive vascular procedures and well-established clinical pathways for peripheral artery disease diagnosis and treatment.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Germany Peripheral Vascular Devices Market Size, 2025: USD 369 Million
• Germany Peripheral Vascular Devices Market Size By 2035: USD 562 Million
• Germany Peripheral Vascular Devices CAGR (2026-2035): 4.29%

Drivers

• Peripheral artery disease affects approximately 2.7 million people in Germany, supporting demand for vascular devices
• Robust health care system with advanced endovascular and interventional radiology services
• Strong adoption of peripheral stents, angioplasty balloons, atherectomy systems and thrombectomy devices
• Investing more in cardiovascular care, vascular diagnostics and interventional technologies Restraints
• Strict regulatory requirements under the European Medical Device Regulation (EU MDR)
• High cost of advanced vascular interventions (both in procedures and operations)
• Statutory healthcare reimbursement systems: budget constraints
• Established and competitive environment of the medical device market

Opportunities

• Rise in use of drug-coated balloon and drug-eluting stent for peripheral interventions
• Increased use of AI-assisted technologies for vascular imaging and treatment planning
• Further emphasis on next-generation bioresorbable vascular scaffolds and customized vascular care solutions

France Peripheral Vascular Devices Market:

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• France Peripheral Vascular Devices Market Size in 2025: USD 258 Million
• 2035 France Peripheral Vascular Devices Market Revenue (USD 384 Million)
• France Peripheral Vascular Devices CAGR (2026-2035): 4.05%

Drivers

• >15 million people in France suffer from chronic cardiovascular diseases, thus requiring vascular interventions
• Strong government support for cardiovascular disease prevention and the modernization of healthcare initiatives
• Increased focus on early diagnosis and treatment of peripheral artery disease and venous disorders
• Growing adoption of minimally invasive endovascular procedures and advanced vascular devices

Restraints

• Budget for procurement of premium vascular technologies in public healthcare is limited
• Limited access to specialized vascular treatment services in some areas
• Administrative and reimbursement complexities for innovative devices
• Some areas have limited access to specialized vascular intervention centers

In 2025, France held about 14.00% of the European Peripheral Vascular Devices Market and was valued at approximately USD 258 million. The market is expected to be supported by factors like robust public healthcare infrastructure, growing prevalence of peripheral artery disease and other vascular disorders, rising adoption of minimally invasive endovascular procedures and increasing use of advanced angioplasty balloons, peripheral stents and atherectomy devices.

Opportunities

• Growth of AI-powered vascular imaging and diagnostic solutions
• Expansion of personalized vascular therapies and next-gen drug-coated device platforms
• Growing utilization of outpatient vascular intervention programs and minimally invasive treatments

Italy Peripheral Vascular Devices Market:

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Italy Peripheral Vascular Devices Market size (USD 184 Million)
• 2035 Italy Peripheral Vascular Devices Market Size: USD 266 Million
• Italy Peripheral Vascular Devices CAGR (2026-2035): 3.73%

Drivers

• Peripheral artery disease and other vascular diseases are estimated to involve about 4 million people in Italy
• Robust public healthcare system for management of cardiovascular and vascular diseases
• Rising demand for angioplasty, stenting, atherectomy and thrombectomy procedures
• Increase in the adoption of advanced endovascular treatment technologies and vascular imaging systems

Restraints

• Stringent regulatory and healthcare compliance requirements of EU MDR
• Advanced vascular interventions have high operational and procedural costs
• Reimbursement programs of public healthcare with budgetary constraints

Opportunities

• Adoption of drug-coated balloon and drug-eluting stent for peripheral interventions to grow
• Boost adoption of AI-assisted vascular imaging, navigation and treatment planning solutions
• More emphasis on personalized vascular care and minimally invasive treatment approaches

Spain Peripheral Vascular Devices Market:

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Spain Peripheral Vascular Devices Market Size 2025: USD 147 Million
• Spain Peripheral Vascular Devices Market Revenue (USD 236 Million) 2035
• Spain Peripheral Vascular Devices CAGR (2026-2035): 4.82%

Drivers

• An estimated 1 million people in Spain suffer from peripheral artery disease, driving demand for vascular interventions
• Strong government support for efforts to prevent cardiovascular disease, and to modernize healthcare
• More emphasis on early diagnosis and treatment of peripheral vascular diseases
• Increasing use of minimally invasive angioplasty, stenting, atherectomy and thrombectomy procedures

Restraints

• Public healthcare budget constraints impact adoption of premium vascular technologies.
• There are delays in access to specialized vascular intervention services in some regions
• Administrative inefficiencies in health-care procurement and reimbursement systems.
• Restricted availability of specialized vascular treatment facilities in rural areas

Opportunities

• Creation of AI-enabled vascular imaging and diagnostic solutions
• Development of personalized approaches to vascular treatment and next generation endovascular devices
• Growing uptake of outpatient vascular intervention and ambulatory care programmes

In 2025, Spain’s share in the European Peripheral Vascular Devices Market stood at roughly 8.00% and was valued at about USD 147 million. The market is driven by the presence of a strong public healthcare system, increasing prevalence of peripheral artery disease (PAD) and other vascular disorders, growing adoption of minimally invasive endovascular procedures, and expanding availability of advanced vascular intervention technologies.

Regional disparities in availability of specialized facilities for vascular treatment

Italy held a share of around 10.00% in 2025 of the European Peripheral Vascular Devices Market, valued at around USD 184 million. The country continues to be one of the key European markets for peripheral vascular devices owing to the presence of a strong public healthcare system, increasing prevalence of peripheral artery disease and rising demand for minimally invasive vascular procedures among adult and geriatric population.

Switzerland Peripheral Vascular Devices Market:

In 2025, Switzerland accounted for approximately 6.00% share in the European Peripheral Vascular Devices Market and was valued at around USD 110 million. In addition, the market is also supported by a highly advanced healthcare system, robust cardiovascular care infrastructure and rising demand for peripheral vascular devices across patients suffering from peripheral artery disease, chronic limb-threatening ischemia and other vascular disorders.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Switzerland Peripheral Vascular Devices Market size is USD 110 Million
• Switzerland Peripheral Vascular Devices Market Size in 2035 – USD 177 Million
• Switzerland Peripheral Vascular Devices Market CAGR (2026–2035): 4.82%

Drivers

• High prevalence of cardiovascular diseases (CVDs), accounting for ~28% of all deaths in Switzerland
• Comprehensive health system with advanced endovascular intervention and vascular surgery capabilities
• There is a high usage of peripheral stents, drug coated balloons, thrombectomy devices and atherectomy systems
• Major investment in healthcare innovation, medical technologies and vascular disease management

Restraints

• High cost of advanced vascular procedures and long-term treatment of diseases
• Tight regulatory and healthcare compliance requirements for medical devices
• Limited availability of highly specialized vascular intervention services in certain areas
• High operational and labor cost of the healthcare sector Opportunities
• Progress in AI-aided vascular imaging, diagnostics and procedural planning technologies
• Expansion of next generation drug-coated balloons, bioresorbable scaffolds and peripheral stent technologies
• Growing acceptance of personalized vascular intervention and minimally invasive surgical techniques

Netherlands Peripheral Vascular Devices Market

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Netherlands Peripheral Vascular Devices Market Size, By 2025: USD 92 Million
• Netherlands Peripheral Vascular Devices Market Revenue in 2035: USD 162 Million
• Netherlands Peripheral Vascular Devices CAGR (2026 – 2035): 5.83%

The peripheral vascular devices market in The Netherlands is witnessing steady growth, driven by the rising prevalence of peripheral artery disease (PAD), an increase in diabetes and cardiovascular disorders, and the increasing adoption of minimally invasive vascular interventions. Growing incidence of vascular diseases associated with aging, chronic limb-threatening ischemia, and venous disorders is driving demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts at hospitals and specialty cardiovascular centers. “Cardiovascular diseases are still among the leading causes of morbidity,” says the Dutch National Institute for Public Health and the Environment (RIVM), “and population aging keeps increasing demand for vascular disease management.” The Dutch healthcare system also supports broader adoption of peripheral vascular technologies through its emphasis on early diagnosis, preventative care and advanced interventional treatment pathways.

Drivers

• Cardiovascular diseases affect 1.7 million people in the Netherlands, which increases the demand for vascular interventions
• Increase in the prevalence of peripheral artery disease especially amongst the elderly and diabetics
• Growing adoption of minimally invasive endovascular procedures and advanced vascular devices
• Expanding multidisciplinary cardiovascular care services to hospitals and specialty clinics

Restraints

• High demand pressure on cardiovascular treatment in public health care systems
• There are some areas where there is a lack of skilled professionals in vascular intervention
• High procedural costs of advanced peripheral vascular technologies
• Restrictions of the reimbursement system in allocating the public healthcare budget

Opportunities

• Creation of AI-enabled platforms for vascular imaging and procedural planning
• Increased use of drug-coated balloons, drug-eluting stents and bioresorbable scaffold technologies
• Increased development of outpatient vascular intervention centers
• Increasing attention on customized vascular treatment pathways and remote patient monitoring

Asia Pacific Peripheral Vascular Devices Market

The Asia Pacific Peripheral Vascular Devices Market is growing at a strong pace owing to increasing prevalence of peripheral artery disease, diabetes, obesity, cardiovascular disorders and rapid growth of healthcare infrastructure in developing economies. The growing burden of vascular diseases, such as chronic limb ischemia, deep vein thrombosis, peripheral arterial occlusive disease, is significantly propelling the demand for angioplasty balloons, peripheral stents, atherectomy systems, thrombectomy devices and vascular grafts. The World Health Organization (WHO) reported that cardiovascular diseases cause approximately 20 million deaths annually worldwide. The Asia Pacific region has a large and increasing population, making it responsible for a significant share of the disease burden. In addition, rising investments in cardiovascular care facilities, better access to minimally invasive procedures, and rising awareness for the early diagnosis of vascular disease are supporting the wider adoption of peripheral vascular devices across the region.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Asia Pacific Peripheral Vascular Devices Market Size 2025: USD 1,344 Million
• Asia Pacific Peripheral Vascular Devices Market Size (USD 2,680 Million in 2035)
• Asia Pacific Peripheral Vascular Devices CAGR (2026-2035): 6.39%

Drivers

• Emerging economies are seeing rapid growth in healthcare infrastructure and cardiovascular treatment centers
• Increased incidence of peripheral artery disease, diabetes and other vascular disorders
• Increased health insurance coverage and rising health care costs
• Better awareness of early detection and minimally invasive treatment of vascular diseases

Restraints

• Inequitable access to advanced vascular intervention services in rural and under-served areas
• Shortage of trained vascular specialists and interventional radiologists in some countries
• Inadequate reimbursement for complex vascular procedures in developing economies
• Changes in healthcare regulations and device approval procedures in Asia Pacific countries

Opportunities

• Large patient population with untreated and underdiagnosed peripheral artery disease
• Fast-paced deployment of AI-enabled vascular imaging and diagnostic technologies
• Development of outpatient vascular intervention programs and ambulatory surgical centers
• Growing demand for next generation drug-coated balloons, peripheral stents and thrombectomy systems

China Peripheral Vascular Devices Market

is steadily growing driven by rising prevalence of peripheral artery disease (PAD), diabetes, cardiovascular disorders and increasing strength of healthcare infrastructure across the country. The increasing prevalence of chronic limb-threatening ischemia, peripheral arterial occlusive disease, and venous disorders is propelling the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals and specialized cardiovascular centers. According to the World Health Organization (WHO), cardiovascular diseases continue to be one of the leading causes of death in China, with the growing burden of vascular diseases aggravated by rapid urbanization, aging population and lifestyle-related risk factors. Also, China’s healthcare reforms to improve access to advanced medical technologies and cardiovascular care services are aiding in integrating peripheral vascular interventions into standard treatment pathways.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 China Peripheral Vascular Devices Market Size: USD 430 million
• China Peripheral Vascular Devices Market Size (2035) – USD 938 Million
• China Peripheral Vascular Devices CAGR (2026-2035) 8.11%

Drivers

• Cardiovascular diseases are affecting over 330 million people in China, resulting in a growing demand for vascular interventions
• Rapid growth of cardiovascular and vascular oriented healthcare services across the country Strong government spending on healthcare infrastructure and advanced medical technologies
• Increased awareness of early diagnosis and minimally invasive treatment of peripheral vascular diseases

Restraints

• Inconsistency in access to advanced vascular intervention services between urban and rural areas
• Shortage of vascular specialists in some areas who are well-trained Provincial variation in regulation and reimbursement.
• High volume of patients in public healthcare institutions affecting access to treatment

Opportunities

• Peripheral vascular device growth and innovation in domestic manufacturing
• Expansion of AI-enabled vascular imaging, diagnostics, and procedural planning platforms
• Investment into programs for managing cardiovascular and vascular disease is on the rise
• Increasing use of telehealth and remote monitoring solutions for vascular patients

India Peripheral Vascular Devices Market

Slow and steady growth of India Peripheral Vascular Devices Market is due to increasing incidence of peripheral artery disease, diabetes, cardiovascular disorders and better accessibility to advanced healthcare services in urban and semi-urban areas. The increasing prevalence of chronic limb ischemia, diabetic foot complications, venous disorders, and stroke-related vascular conditions is driving the demand for peripheral stents, angioplasty balloons, thrombectomy devices, atherectomy systems, and vascular grafts in hospitals, specialty cardiovascular centers and private healthcare establishments. According to the World Health Organization (WHO), cardiovascular diseases account for nearly 28% of all deaths in India, indicating the heavy burden of vascular disorders. Additionally, government initiatives to enhance cardiovascular care, develop healthcare infrastructure, and promote the adoption of digital health are further supporting the increased use of peripheral vascular interventions.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Devices Market Size: USD 188 Million in 2025
• India Peripheral Vascular Devices Market Size By 2035: USD 455 Million
• India Peripheral Vascular Devices CAGR (2026-2035) 9.25%

Drivers

• A nationwide extended network of hospitals, cardiac and vascular intervention facilities
• Over 101 million adults in India are estimated to be living with diabetes, a major risk factor for peripheral artery disease.
• The increasing burden of cardiovascular and peripheral vascular disorders in aging populations
• Government-led healthcare digitization and investment in advanced infrastructure for cardiovascular care

Restraints

• Insufficient number of trained vascular specialists in rural and semi-urban areas
• High out-of-pocket expenditure for advanced vascular procedures and cost sensitivity
• Uneven infrastructure for vascular intervention and healthcare across states
• Some advanced peripheral vascular treatments have limited insurance coverage

Opportunities

• Increasing access to affordable peripheral vascular intervention services in Tier 2 and Tier 3 cities
• Increase in multi-specialty hospitals and specialized cardiovascular care centers
• Increasing adoption of AI-enabled vascular imaging and diagnostic technologies
• Increasing demand for locally produced peripheral stents, angioplasty balloons and thrombectomy devices

Japan Peripheral Vascular Devices Market

is booming with a CAGR of 4.78% during the forecast period 2026-2035. The Japanese population is aging rapidly and the prevalence of peripheral artery disease (PAD), diabetes, chronic limb-threatening ischemia, and other vascular disorders is increasing with age. As Japan continues to build out its cardiovascular and geriatric healthcare infrastructure, hospitals, cardiovascular centers and long term care facilities are seeing an increased demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts. The Ministry of Health, Labour and Welfare (MHLW) said that cardiovascular and vascular diseases are becoming a heavy burden on the country, with more than 29% of Japan’s population aged 65 years and above. In addition, the country’s strong emphasis on the development of advanced healthcare technologies is driving the adoption of AI-assisted vascular imaging, robotic-assisted interventions, and next-generation endovascular treatment solutions.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Japan Peripheral Vascular Devices Market Revenue 2025: USD 268 Million
• 2035 Japan Peripheral Vascular Devices Market Value: USD 428 Million
• Japan Peripheral Vascular Devices CAGR (2026-2035): 4.78%

Drivers

• With more than 36 million people aged 65 years and older, Japan has seen increased demand for vascular disease management
• Advanced healthcare infrastructure to support specialized cardiovascular and vascular interventions
• High adoption rate of minimally invasive endovascular procedures and new vascular devices
• Strong government focus on healthy aging, chronic disease management and long-term care programs

Restraints

• Mature healthcare market with limited opportunities for rapid growth
• Some rural and aging communities lack access to specialized vascular intervention professionals
• Rigid regulatory and reimbursement environment for medical devices
• High cost of sophisticated vascular technologies and interventional techniques

Opportunities

• Expansion of AI-based solutions for vascular imaging and treatment planning
• Development of post-procedure surveillance and vascular services at home
• Growing need for peripheral artery disease and chronic limb ischemia treatment programs
• Next generation drug-coated balloons, bioresorbable scaffolds and precision vascular therapies

South Korea Peripheral Vascular Devices Market

is surging owing to an increase in prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular disorders as well as strong government support for healthcare modernization and advanced medical technologies. The increasing prevalence of chronic limb ischemia, peripheral arterial occlusive disease and vascular complications related to aging is driving the demand for peripheral stents, angioplasty balloons, thrombectomy devices, atherectomy systems and vascular grafts in hospitals and specialized cardiovascular centers. The country is quickly turning into a super-aged society, which is increasing the burden of chronic vascular diseases, according to Statistics Korea (KOSTAT). Moreover, the robust healthcare infrastructure of South Korea and the increasing penetration of digital health technologies are facilitating the wider adoption of AI-based vascular diagnostics, imaging platforms, and minimally invasive intervention techniques.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Size of South Korea Peripheral Vascular Devices Market in 2025: USD 121 Million
• 2035 South Korea Peripheral Vascular Devices Market Size: USD 227 Million
• South Korea Peripheral Vascular Devices Market CAGR (2026-2035): 6.54%

Drivers

• Increase in prevalence of vascular disorders due to more than 20% of South Korea’s population being aged 65 years and above
• Robust healthcare infrastructure and sophisticated cardiovascular care ecosystem
• Government initiatives for digital healthcare transformation and adoption of medical technology
• Greater use of minimally invasive endovascular procedures and advanced vascular devices

Restraints

• Intense competition between manufacturers of domestic and international medical devices
• Complexity of regulation and reimbursement for advanced vascular technologies
• Disparities in access to specialized vascular intervention services in some rural areas
• Reliance on highly trained vascular specialists and interventional radiologists

Opportunities

• Growth of AI-led vascular imaging, diagnostics and procedural guidance platforms
• Ambulatory surgical center expansion and outpatient vascular intervention
• Growing need for telehealth-based vascular disease management solutions
• More funding for individualized cardiovascular and peripheral vascular treatment programs

Singapore Peripheral Vascular Devices Market

The Singapore Peripheral Vascular Devices Market is expected to grow at a steady rate, owing to advanced healthcare infrastructure, rising prevalence of peripheral artery disease (PAD), diabetes, and cardiovascular disorders, and government initiatives towards improving chronic disease management and preventive healthcare. Hospitals, specialty cardiovascular centers and private healthcare institutions are all looking for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts to serve the increasing number of patients suffering from diabetic vascular complications, chronic limb ischemia, venous disorders and age-related cardiovascular diseases. Singapore's Ministry of Health (MOH) recognises chronic diseases as a major healthcare concern with cardiovascular diseases being a major driver of healthcare utilization. Moreover, Singapore’s focus on healthcare digitization is driving the adoption of AI-assisted vascular imaging, minimally invasive interventions and remote patient monitoring solutions.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Singapore Peripheral Vascular Devices Market Size: USD 40.3 million
• Singapore Peripheral Vascular Devices Market Size, By 2035: USD 80.4 Million
• Singapore Peripheral Vascular Devices CAGR (2026-2035) 7.15%

Drivers

• Estimates suggest that over 400,000 adults in Singapore are living with diabetes, a major risk factor for peripheral artery disease
• Strong, mature healthcare system offering advanced cardiovascular and vascular care
• Growing prevalence of cardiovascular and peripheral vascular diseases owing to aging population
• Government assistance for preventive health care, chronic disease management and health care innovation Restraints
• High cost of advanced vascular devices and therapies
• Small cadre of specialized vascular and interventional specialists
• Availability of treatment depends on public healthcare capacity
• Limited space and resources in certain public health facilities

Opportunities

• Creation of AI-powered platforms for vascular imaging and diagnostics
• Increase in private specialist centres for vascular and cardiovascular care
• Rising adoption of outpatient vascular intervention procedures
• Use of latest drug coated balloons, peripheral stents and remote monitoring technologies

Australia Peripheral Vascular Devices Market

The Australia Peripheral Vascular Devices Market is anticipated to experience a steady growth in the forecast period of 2023-2028. The market is expected to be driven by factors like advanced healthcare infrastructure, increasing prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular disorders, and rising demand for minimally invasive vascular interventions in adult and geriatric populations. Increasing burden of chronic limb ischemia, diabetic vascular complications, venous diseases, and age-related cardiovascular conditions are driving high utilization of angioplasty balloons, peripheral stents, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals, specialty cardiovascular centers, and community healthcare settings. Cardiovascular disease affects about 1.3 million Australians and is a leading cause of morbidity and mortality in the country, the Australian Institute of Health and Welfare (AIHW) said. There is also a strong focus on public healthcare access and chronic disease management programs in Australia, which is helping to propel the wider adoption of advanced peripheral vascular technologies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Australia Peripheral Vascular Devices Market Size: USD 87.4 Million
• 2035 Revenue (USD 147 Million) of Australia Peripheral Vascular Devices Market
• Australia Peripheral Vascular Devices CAGR (2026-2035): 5.37%

Drivers

• Integrated health care system with advanced cardiovascular and vascular care services
• An estimated 1.3 million Australians have cardiovascular disease, providing opportunities for vascular interventions
• Strong government support in chronic disease management and healthcare modernization programs
• Increased adoption of minimally invasive endovascular surgeries and advanced vascular technologies

Restraints

• High procedural and device costs of advanced vascular interventions
• shortages of specialized cardiovascular and vascular healthcare staff
• Variations in vascular treatment facilities in rural and remote areas
• Medical device providers are subject to strict regulatory and compliance requirements

Opportunities

• Improved telehealth-enabled vascular disease monitoring and follow-up care
• Expansion of outpatient vascular intervention and ambulatory surgery centers
• The use of AI-assisted vascular imaging, diagnostics and procedural planning tools will grow
• Increasing private sector investment in the provision of cardiovascular and peripheral vascular treatment services

Thailand Peripheral Vascular Devices Market

Peripheral Vascular Devices Market (Historical, Current, Forecast):

The Thailand Peripheral Vascular Devices Market is expected to grow at a significant rate owing to the increasing prevalence of peripheral artery disease (PAD), cardiovascular and diabetes disorders, improving healthcare infrastructure, and increasing focus of governments on strengthening cardiovascular and vascular care services. The increasing incidence of diabetic vascular complications, chronic limb ischemia, deep vein thrombosis, and age-related vascular disorders in hospitals, specialty cardiovascular centers, and rehabilitation facilities is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts. According to the World Health Organization (WHO), non-communicable diseases contribute to more than 70% of all deaths in Thailand, and cardiovascular diseases are a major contributor. Moreover, Thailand’s healthcare reforms and the expansion of universal healthcare coverage are helping to ensure wider access to advanced vascular diagnostics and minimally invasive interventions.

• Thailand Peripheral Vascular Devices Market Size by 2025: USD 40.3 Million
• Thailand Peripheral Vascular Devices Market Size – USD 93.8 Million by 2035
• Thailand Peripheral Vascular Devices CAGR (2026-2035): 8.81%

Drivers

• Development of cardiovascular facilities and public health infrastructure
• Increasing incidence of diabetes and cardiovascular diseases, key risk factors of peripheral artery disease
• Strong government emphasis on universal access to healthcare and chronic disease management.
• Increasing number of minimally invasive vascular intervention procedures

Restraints

• Scarcity of specialized vascular intervention professionals in rural areas
• Unequal distribution of specialized vascular treatment services in the provinces
• Financial limitations in public health institutions
• Poor knowledge of symptoms of peripheral vascular disease in some rural populations

Opportunities

• AI-powered vascular imaging and diagnostic platforms development
• Expansion of ambulatory care services and outpatient vascular intervention
• Growing private sector investment in cardiovascular and vascular treatment facilities
• Development of next –generation drug coated balloons, peripheral stents and thrombectomy technologies.

Malaysia Peripheral Vascular Devices Market

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Malaysia Peripheral Vascular Devices Market size to hit USD 33.6 Million
• Malaysia Peripheral Vascular Devices Market size to USD 80.4 Million by 2035
• Malaysia Peripheral Vascular Devices CAGR 2026-2035 — 9.12%

Drivers

• Growing network of public and private hospitals providing cardiovascular and vascular care services
• An estimated 3.9 million adults in Malaysia are living with diabetes, which raises the risk of peripheral artery disease
• Growing prevalence of cardiovascular and vascular disorders in aging populations
• Government initiatives supporting healthcare modernization and digital health transformation

The Malaysia Peripheral Vascular Devices Market is witnessing a steady growth rate due to the increasing prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular diseases, and the improving access to healthcare in the public and private sectors gradually. Increasing prevalence of diabetic vascular complications, chronic limb ischemia, peripheral arterial occlusive disease, and venous disorders is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals, cardiovascular centers, and specialty vascular clinics. Cardiovascular diseases continue to be among the top causes of mortality in Malaysia, while the increasing prevalence of diabetes further increases the risk of peripheral vascular disorders, according to the Ministry of Health Malaysia. Furthermore, the country is witnessing healthcare reforms and expansion of digital healthcare services, which are improving access to advanced vascular diagnostics and minimally invasive treatment options.

Restraints

• inequities in access to specialized vascular intervention services in rural and remote regions
• Lack of trained vascular surgeons and interventional specialists
• High out-of-pocket expenses for advanced vascular procedures in private health-care settings
• Lower awareness of peripheral artery disease (PAD) and long-term vascular disease management in some locations

Opportunities

• Expansion of telehealth-enabled monitoring and follow-up of vascular diseases
• Specialized cardiovascular centres and the rise in private healthcare investment
• Increased investment in advanced vascular imaging and minimally invasive intervention technologies
• AI-assisted diagnostic, procedural planning and vascular treatment tools

Indonesia Peripheral Vascular Devices Market

The Indonesia Peripheral Vascular Devices Market is anticipated to grow steadily during the forecast period. The growth can be attributed to the rising prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular disorders, and the continuous improvement of healthcare infrastructure in urban and semi-urban regions. The growing incidence of diabetic foot complications, peripheral arterial occlusive disease, chronic limb ischemia and other vascular disorders is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, specialty cardiovascular centers and private clinics. World Health Organization (WHO) states that non-communicable diseases are responsible for 73% of total deaths in Indonesia, with a significant contribution from cardiovascular diseases. Furthermore, Indonesia’s healthcare reforms and expansion of universal health coverage (JKN) are improving access to advanced cardiovascular and vascular care services.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Indonesia Peripheral Vascular Devices Market Size, 2025: USD 67 Million
• Indonesia Peripheral Vascular Devices Market Size, 2035: USD 147 Million
• Indonesia Peripheral Vascular Devices CAGR (2026-2035): 8.17%

Drivers

• National healthcare system and cardiovascular treatment infrastructure expansion
• Estimates suggest that more than 19 million adults in Indonesia are living with diabetes, which significantly increases the risk of peripheral artery disease
• More common cardiovascular and peripheral vascular disorders
• Expansion of universal health coverage (JKN) and healthcare modernization by government

Restraints

• limited number of qualified vascular specialists in rural and remote areas
• Disparity of access to advanced vascular treatment services among Indonesian islands
• High out-of-pocket costs for specialized vascular interventions.
• Some rural communities lack knowledge about the signs and symptoms and treatment options for peripheral vascular disease

Opportunities

• Expansion of telehealth and digital vascular disease management platform
• Development of specialised cardiovascular and vascular care centres
• Strong investment in private healthcare and medical technology
• AI-based tools for vascular imaging, diagnostics and intervention planning

Middle East & Africa Peripheral Vascular Devices Market

The Middle East & Africa Peripheral Vascular Devices Market is growing steadily owing to the rising prevalence of peripheral artery disease (PAD), diabetes, obesity, cardiovascular disorders and continuous advancements in healthcare infrastructure in several countries of the region. The growing prevalence of diabetic vascular complications, chronic limb ischemia, deep vein thrombosis, and other vascular disorders are driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals, cardiovascular centers, and specialty clinics. Non-communicable diseases (NCDs) account for around 74% of deaths globally, with cardiovascular diseases being the most common cause, and they represent a huge burden in many countries in the Middle East and Africa, according to the World Health Organization (WHO). In addition, government initiatives for modernizing healthcare and increasing private sector investment in healthcare are supporting the adoption of advanced vascular intervention technologies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Middle East & Africa Peripheral Vascular Devices Market Size (2025): USD 235 Million
• Middle East & Africa Peripheral Vascular Devices Market Size: USD 391 Million in 2035
• Middle East & Africa Peripheral Vascular Devices CAGR (2026-2035): 3.78%

Drivers

• Improved investment in healthcare infrastructure and cardiovascular care services
• Rising prevalence of diabetes, obesity and cardiovascular disorders in the region
• Increase in minimally invasive vascular intervention procedures adoption
• Growing government health programs aimed at managing chronic diseases

Restraints

• Limited access to specialized vascular intervention services in many areas of the world
• Disparities exist in healthcare infrastructure and cardiovascular treatment between countries
• High dependence on imported vascular devices and medical technologies
• Budget limitations in public health care systems impacting advanced device uptake

Opportunities

• Creating private health care facilities and special cardiovascular centers
• Increasing adoption of AI-based vascular imaging and diagnostic technologies
• Growing demand for minimally invasive vascular procedures and outpatient care
• Increasing adoption of next generation peripheral stents, drug-coated balloons and thrombectomy systems

Saudi Arabia Peripheral Vascular Devices Market

The Saudi Arabia Peripheral Vascular Devices Market is growing steadily as a result of increasing prevalence of diabetes, peripheral artery disease, obesity and cardiovascular diseases and continuous healthcare transformation due to national reform initiatives. The rising prevalence of diabetic vascular complications, chronic limb-threatening ischemia, venous diseases, and other cardiovascular diseases are propelling the expansion of peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts across hospitals, cardiovascular centers, and specialized clinics. The International Diabetes Federation (IDF) estimates that around 18% of the adult population in Saudi Arabia lives with diabetes, placing the country among the highest-prevalence diabetes markets in the world and significantly increasing the risk of peripheral vascular disease. Also, Saudi Arabia’s healthcare transformation initiatives under Vision 2030 are improving access to advanced cardiovascular care and minimally invasive vascular interventions.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Saudi Arabia Peripheral Vascular Devices Market Size: USD 58.8 Million
• Saudi Arabia Peripheral Vascular Devices Market Size, 2035 USD 105.6 Million
• Saudi Arabia Peripheral Vascular Devices CAGR (2026-2035): 6.03%

Drivers

• Expansion of healthcare infrastructure through Vision 2030 health transformation programs
• Adult diabetes prevalence ~18% with higher burden of peripheral artery disease and vascular complications
• Increasing prevalence of cardiovascular and peripheral vascular disease
• Strong government focus on quality of healthcare and chronic disease management.

Restraints

• Scarcity of highly specialized vascular intervention professionals in some regions
• Ongoing use of public healthcare facilities for advanced vascular treatments
• Disparities in access to vascular care services in rural and remote areas
• Costly advanced vascular procedures in the private healthcare

Opportunities

• Development of AI-enabled vascular imaging and minimally invasive intervention technologies
• Increased private investment in healthcare and specialized cardiovascular centers
• Growing use of outpatient vascular procedures and ambulatory care models
• Increase in demand for advanced drug coated balloons, peripheral stents and thrombectomy systems

United Arab Emirates Peripheral Vascular Devices Market

The United Arab Emirates Peripheral Vascular Devices Market is growing at a steady rate due to the presence of highly developed healthcare system, rise in the prevalence of diabetes, obesity, peripheral artery disease (PAD) and cardiovascular disorders, and strong government investment in advanced medical technologies and specialized healthcare services. The growing incidence of diabetic vascular complications, chronic limb ischemia, venous diseases and age-related cardiovascular diseases is fueling the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers and private specialty clinics. According to the International Diabetes Federation (IDF), approximately 20% of adults in the UAE have diabetes, significantly raising the risk of peripheral vascular disease. Moreover, the health care transformation strategies of the UAE are enabling the quick adoption of minimally invasive vascular interventions, AI-enabled diagnostics, and digital healthcare solutions.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 United Arab Emirates Peripheral Vascular Devices Market Size: USD 37.6 Million
• 2035 United Arab Emirates Peripheral Vascular Devices Market Revenue: USD 70.4 Million
• United Arab Emirates Peripheral Vascular Devices CAGR (2026-2035): 6.46% Drivers
• Advanced healthcare infrastructure with robust cardiac and vascular treatment capabilities
• ~20% adult prevalence of diabetes increasing the burden of vascular complications and peripheral artery disease
• Strong government support for healthcare innovation and advanced medical technology
• Adoption of minimally invasive endovascular procedures and AI-enabled healthcare solutions

Restraints

• High cost of sophisticated vascular procedures and specialized medical devices
• Competition among private health care providers in developed urban markets
• Shortage of highly specialized vascular intervention professionals in some regions
• Commercialization of Medical Devices: Licensing and Regulatory Requirements

Opportunities

• Expansion of AI-powered vascular imaging and procedural planning technologies
• Rise in investment in specialized cardiovascular and vascular centers in the private sector
• Increase in demand for outpatient vascular interventions and ambulatory care services
• Integration of digital health platforms and remote monitoring solutions for vascular patients

South Africa Peripheral Vascular Devices Market

The South Africa Peripheral Vascular Devices Market is gradually increasing with the rising prevalence of peripheral artery disease, diabetes, hypertension and cardiovascular disorders along with the constant improvements in public and private healthcare infrastructure. The growing cases of diabetic foot complications, chronic limb ischemia, vascular conditions linked to stroke and venous disorders are driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals, cardiovascular centers, and community healthcare settings. More than 50% of deaths in South Africa are from non-communicable diseases, with cardiovascular diseases a major contributor, according to the World Health Organization (WHO). Moreover, healthcare reforms and rising investment in specialized cardiovascular services are improving access to diagnosis and treatment of vascular diseases.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 South Africa Peripheral Vascular Devices Market Size in USD 49.4 Million
• 2035 South Africa Peripheral Vascular Devices Market Size, USD 70.4 Million
• South Africa Peripheral Vascular Devices CAGR (2026-2035) 3.60%

Drivers

• Development of health care and cardiological treatment systems in public and private sectors
• Increase in incidence of diabetes, hypertension and cardiovascular diseases increasing the vascular disease burden
• Heightened awareness of early diagnosis and treatment of peripheral vascular disease
• Government efforts to reinforce the health care system and management of chronic diseases

Restraints

• Shortage of trained vascular surgeons and interventionalists in many areas
• Disparities in access to higher levels of vascular care: urban vs rural
• High out of pocket expenditure for specialised vascular procedures in the private health care facilities
• Limited infrastructure for cardiovascular and vascular intervention in resource-limited settings

Opportunities

• Growth of telehealth-assisted vascular disease monitoring and follow-up
• Development of community-based screening programs and early intervention for cardiovascular disease
• Increase private investments in cardiovascular and vascular treatment facilities
• Implementation of AI-based vascular imaging, diagnostics and minimally invasive intervention technologies

Egypt Peripheral Vascular Devices Market

The Egypt Peripheral Vascular Devices Market is growing at a slow pace as the prevalence of peripheral artery disease (PAD), diabetes, hypertension and cardiovascular disorders is increasing with the continuous improvement in the healthcare access in urban and semi-urban areas. Increasing number of peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts required in hospitals, cardiovascular centers, and private healthcare facilities is attributed to the increasing incidence of diabetic vascular complications, chronic limb ischemia, venous diseases, and stroke-related vascular conditions. According to the International Diabetes Federation (IDF), Egypt is one of the largest diabetes markets in the Middle East and Africa, with over 11 million adults living with diabetes, putting them at greater risk of peripheral vascular disease. Egypt’s healthcare reforms and extension of universal health coverage initiatives are also enhancing access to cardiovascular and vascular treatment services.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Egypt Peripheral Vascular Devices Market to Reach USD 21.2 Million
• 2035 Egypt Peripheral Vascular Devices Market Size (USD 35.2 Million)
• CAGR of Egypt Peripheral Vascular Devices (2026-2035): 5.21%

Drivers

• Strengthening cardiovascular care in the public and private health care sectors
• The growing problem of peripheral artery disease, affecting more than 11 million adults with diabetes
• Rising prevalence of cardiovascular and peripheral vascular disease
• Government health care reforms and universal health coverage initiatives leading to increased access to treatment

Restraints

• Shortage of trained vascular specialists and interventional professionals
• Limited access to advanced vascular intervention services in rural and underserved areas
• High out-of-pocket cost for specialized vascular procedures
• Infrastructure and resource limitations exist in public healthcare settings

Opportunities

• Expand telehealth-enabled management and follow-up services for vascular disease
• Establishment of specialized cardiovascular and vascular care centers
• Private healthcare investment in advanced vascular treatment technologies
• Use of AI-based vascular imaging, diagnostics and intervention planning tools

Israel Peripheral Vascular Devices Market

The peripheral vascular devices market in Israel is well-developed and growing at a steady pace. This growth is driven by the presence of advanced healthcare infrastructure, increasing incidence of peripheral artery disease, diabetes, and cardiovascular disorders, and the robust integration of innovative vascular treatment technologies within public and private healthcare systems. The demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, specialty cardiovascular centers and community healthcare programs is driven by increasing prevalence of chronic limb ischemia, diabetic vascular complications, venous diseases and age-related cardiovascular disorders. According to the Organisation for Economic Co-operation and Development (OECD), approximately 13% of Israel’s population is aged 65 years and above, leading to growing need for management of vascular disease and minimally invasive interventions. Furthermore, Israel's strong focus on medical innovation and digital health is accelerating the adoption of AI-assisted vascular imaging, diagnostics and advanced endovascular therapies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Israel Peripheral Vascular Devices Market Revenue Size: USD 28.2 million
• 2035 Israel Peripheral Vascular Devices Market Size: USD 50.8 Million
• Israel Peripheral Vascular Devices CAGR (2026-2035) : 6.06%

Drivers

• Good healthcare infrastructure with strong cardiovascular and vascular treatment ecosystem
• Rising prevalence of cardiovascular diseases, diabetes and peripheral artery disease
• High awareness and early diagnosis of chronic vascular diseases
• High adoption of digital health technologies and innovative vascular intervention solutions

Restraints

• The high cost of complex vascular procedures and specialty medical devices
• Limited availability of highly specialized vascular professionals in some regions
• Mature healthcare market with high competition among medical device suppliers
• Regulatory and reimbursement challenges for new vascular technologies

Opportunities

• Developing AI-enabled vascular imaging and intervention planning platforms
• Expansion of outpatient vascular intervention and ambulatory care programs
• Growing demand for telehealth-enabled vascular disease management services
• Increasing integration of advanced peripheral vascular devices into multidisciplinary cardiovascular care models.

Latin America Peripheral Vascular Devices Market

The Latin America Peripheral Vascular Devices Market is expected to grow at a steady CAGR in the forecast period. The growth is expected to be driven by the increasing incidence of peripheral artery disease (PAD), diabetes, obesity and cardiovascular disorders, and persistent improvement in healthcare access in public and private healthcare systems. The growing incidence of diabetic vascular complications, chronic limb ischemia, venous diseases, and vascular conditions due to stroke is boosting the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems, and vascular grafts in hospitals, cardiovascular centers, and specialty clinics. According to the World Health Organization (WHO), cardiovascular diseases continue to be the leading cause of death in the Americas, with a death toll of around 2 million annually, creating a large demand for diagnosis and treatment of vascular diseases. Moreover, rising adoption of peripheral vascular intervention devices is being fueled by the promotion of universal health coverage and an increase in cardiovascular care services.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Latin America Peripheral Vascular Devices Market Size 2025: USD 436 Million
• 2035 Latin America Peripheral Vascular Devices Market Size is USD 726 Million
• CAGR of Latin America Peripheral Vascular Devices (2026-2035): 5.16%

Drivers

• Increase in awareness regarding early diagnosis and management of peripheral artery disease and cardiovascular disorders
• Growing healthcare spending in emerging markets in Latin America
• Growth of specialized vascular care providers and private sector cardiovascular hospitals
• Increasing demand for minimally invasive vascular interventions in diabetic and aging populations

Restraints

• Many countries have economic instability and limited funding for healthcare
• Variations in availability of cutting-edge vascular treatment services in urban and rural areas
• Limited insurance and reimbursement coverage for some vascular procedures
• Dependence on peripheral vascular devices and medical technologies from overseas.

Opportunities

• Increased public-private partnerships in healthcare with focus on cardiovascular disease management
• Expansion of digital health platforms and AI-based vascular imaging
• Increased use of outpatient vascular intervention procedures
• Demand is growing for affordable peripheral stents, angioplasty balloons and thrombectomy devices

Brazil Peripheral Vascular Devices Market

The Brazil Peripheral Vascular Devices Market is growing at a steady rate owing to increasing prevalence of peripheral artery disease (PAD), diabetes, obesity and cardiovascular disorders. Furthermore, the growth of the market is supported by continuous improvements in the accessibility of healthcare in both public and private systems. The increasing incidence of diabetic vascular complications, chronic limb ischemia, venous disorders and vascular conditions associated with stroke is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers, specialty clinics and ambulatory surgical facilities. Brazil has more than 16 million adults with diabetes, making it one of the largest diabetes markets in the world and a major contributor to the burden of peripheral vascular disease, said the International Diabetes Federation (IDF). The Unified Health System (SUS) in Brazil, coupled with the growing private health sector, is driving the adoption of minimally invasive vascular intervention technologies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Brazil Peripheral Vascular Devices Market Size 2025: USD 183 Million
• Brazil Peripheral Vascular Devices Market Size USD 290 Million in 2035
• Brazil Peripheral Vascular Devices CAGR (2026-2035): 4.70%

Drivers

• Expansion of the public health system (SUS) and increasing private network of cardiovascular care
• Over 16 million adults with diabetes – higher rates of peripheral artery disease, vascular complications
• Rise in the occurrence of cardiovascular diseases, obesity and hypertension
• Growing demand for endovascular surgery and minimally invasive vascular surgery

Restraints

• Unequal access to specialized vascular treatment services in urban and rural areas
• High out of pocket cost for specialized vascular procedures in private health care facilities
• Vascular and interventional specialists shortages in underserved areas.
• Dependence on imported medical technologies and peripheral vascular devices

Opportunities

• Development of telehealth platforms for monitoring vascular disease
• Establishment of specialist centres for cardiovascular and vascular disease management
• Increased investment in private health infrastructure and the latest endovascular technologies
• Deploying AI-enabled vascular imaging, diagnostics and procedural planning solutions

Mexico Peripheral Vascular Devices Market

Peripheral Vascular Devices Market (Historical, Current, Forecast):

The Mexico Peripheral Vascular Devices Market is growing at a slower pace due to the rising prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular diseases, and the continuous improvement in healthcare access in public and private healthcare systems. Rising prevalence of diabetic foot problems, chronic limb ischemia, venous diseases and vascular conditions associated with stroke are propelling demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers and specialty clinics. The International Diabetes Federation (IDF) estimates that there are 14 million adults living with diabetes in Mexico, making it one of the countries with the largest global diabetes burden, and considerably increasing the need for management of vascular disease. In addition, the growth of healthcare systems and increasing investments in cardiovascular care infrastructure are driving the growing adoption of advanced vascular intervention technologies.

• Mexico Peripheral Vascular Devices Market Size, By 2025 USD 96.1 Million
• Mexico Peripheral Vascular Devices Size in 2035: USD 152.5 Million
• Mexico Peripheral Vascular Devices CAGR (2026-2035) 4.72%

Drivers

• Creation of networks of public health services and private cardiovascular clinics
• Approximately 14 million adults with diabetes; associated with increased vascular complications and peripheral artery disease * Increasing prevalence of obesity, hypertension and cardiovascular diseases
• Increasing demand for endovascular and vascular interventions for minimally invasive surgeries

Restraints

• Limited permanent access to advanced vascular treatment services in rural and underserved areas
• High out-of-pocket costs for specialized vascular procedures
• Lack of trained vascular specialists in some parts
• Reliance on imported peripheral vascular devices and advanced medical technologies

Opportunities

• Telehealth and digital platforms are growing for vascular disease management
• Creation of specialized cardiovascular and vascular intervention centers
• Increased investment in private health care and endovascular treatment facilities
• Introducing AI-powered vascular imaging, diagnostics, and procedural planning technologies

Argentina Peripheral Vascular Devices Market

The peripheral vascular devices market in Argentina is witnessing consistent growth, driven by the rising prevalence of peripheral artery disease (PAD), diabetes, obesity, and cardiovascular disorders, along with the continuous improvement of healthcare service delivery in both the public and private sectors. Peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts are in demand due to the increasing prevalence of diabetic vascular complications, chronic limb ischemia, venous disorders and stroke-related vascular conditions in hospitals, cardiovascular centers, specialty clinics and outpatient facilities. According to estimates from the International Diabetes Federation (IDF), Argentina has 6 million adults with diabetes, a condition that increases the risk of peripheral vascular disease and complications associated with it. Argentina’s hybrid public-private healthcare system is also enabling a gradual increase in access to advanced vascular diagnostics and minimally invasive treatment procedures.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Argentina Peripheral Vascular Devices Market Size, USD 43.7 Million in 2025
• Argentina Peripheral Vascular Devices Market Size in 2035: USD 72.6 Million
• Argentina Peripheral Vascular Devices CAGR (2026-2035): 5.21%

Drivers

• Strong public and private health care infrastructure including cardiovascular and vascular care services
• Higher demand for peripheral vascular interventions in approximately 6 million diabetes adults
• Increasing prevalence of obesity, hypertension and cardiovascular diseases
• Growing role of minimally invasive endovascular procedures in the management of vascular diseases

Restraints

• Medical device and healthcare spend threatened by economic instability
• Geographic gaps in access to advanced vascular care
• Limited availability of specialized vascular surgeons and interventionalists in certain regions
• Heavy reliance on imported peripheral vascular devices and technologies

Opportunities

• Supporting the development of telehealth platforms for monitoring and management of vascular disease
• More vascular and cardiovascular specialty care centers
• Foster more private investment in advanced endovascular technologies in healthcare
• Deployment of AI-based vascular imaging, diagnostics and procedural planning solutions

Chile Peripheral Vascular Devices Market

The Chile Peripheral Vascular Devices Market is expected to register a steady CAGR during the forecast period (2018-2024) due to the increasing prevalence of peripheral artery disease, diabetes, cardiovascular disorders and continuous strengthening of healthcare infrastructure across public and private sector. The rising prevalence of diabetic foot complications, chronic limb ischemia, venous diseases and age-related vascular diseases is fueling demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers and outpatient care facilities. The International Diabetes Federation (IDF) estimates that more than 2 million adults in Chile are living with diabetes, representing a large patient population at risk of peripheral vascular disease. Moreover, the higher healthcare infrastructure in Chile and rising adoption of digital health and cardiovascular care services are further propelling the wider adoption of minimally invasive vascular intervention technologies.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• 2025 Chile Peripheral Vascular Devices Market Size, USD 26.2 Million
• Chile Peripheral Vascular Devices Market Size (USD 47.2 Million) 2035
• Chile Peripheral Vascular Devices CAGR (2026-2035): 6.06% Drivers
• Rising prevalence of cardiovascular diseases and age-related vascular disorders
• Increased acceptance of minimally invasive vascular interventions and endovascular procedures

Restraints

• Rural disparities in access to specialized vascular treatment services
• High out-of-pocket expenses for cardiovascular and vascular private care
• Some areas do not have trained vascular specialists
• reliance on imported peripheral vascular devices and high-tech medical equipment

Opportunities

• Rise in telehealth and digital platforms for vascular disease management
• Development of dedicated cardiovascular and vascular intervention centers
• More investment in private healthcare for sophisticated vascular treatment services
• Using AI-enabled tools for vascular imaging, diagnostics and procedure planning Bibliography

Colombia Peripheral Vascular Devices Market

The increasing prevalence of peripheral artery disease (PAD), diabetes, obesity, and cardiovascular disorders, and the continuous improvements in healthcare access in both urban and rural regions are gradually increasing the Colombia Peripheral Vascular Devices Market. There is an increasing incidence of diabetic foot complications, chronic ischemia of limbs, venous diseases and vascular diseases associated with stroke, which is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers, specialty clinics and private healthcare institutes. According to the International Diabetes Federation (IDF) there are about 4 million adults with diabetes in Colombia, which significantly increases the risk of peripheral vascular disease and its complications. In addition, healthcare reforms and implementation of universal coverage programs in Colombia are aiding in the improvement of access to cardiovascular and vascular intervention services.

Peripheral Vascular Devices Market (Historical, Current, Forecast):

• Colombia Peripheral Vascular Devices Market Size, By 2025 : USD 30.6 Million
• Colombia Peripheral Vascular Devices Market Revenue to Reach USD 58.1 Million by 2035
• Colombia Peripheral Vascular Devices CAGR (2026-2035) 6.63%

Drivers

• Improved access to health care and cardiovascular rehabilitation services
• The need for treatment of peripheral artery disease is increased by the fact that approximately 4 million adults have diabetes
• Rising prevalence of obesity, hypertension and cardiovascular diseases
• Increase in public and private health care facilities offering vascular intervention

Restraints

• Disparities in access to specialized vascular treatment services in rural settings
• High out-of-pocket cost for specialized vascular procedures.
• Lack of trained vascular surgeons and interventional specialists
• Dependence upon sophisticated imported medical technologies and peripheral vascular devices

Opportunities

• The rise of platforms for managing vascular disease enabled by telehealth
• Creation of specialized centers for the treatment of cardiovascular and vascular diseases
• Growing private investment in vascular intervention services
• Deploying AI-powered vascular imaging, diagnostics and procedural planning technologies

Peru Peripheral Vascular Devices Market

The peru peripheral vascular devices market is anticipated to be boosted by the increasing prevalence of peripheral artery disease, diabetes, obesity, and cardiovascular disorders along with the growing healthcare infrastructure in the urban areas. Increasing incidence of diabetic vascular complications, chronic limb ischemia, venous disorders and age-related vascular diseases is driving the demand for peripheral stents, angioplasty balloons, atherectomy devices, thrombectomy systems and vascular grafts in hospitals, cardiovascular centers, specialty clinics and private healthcare facilities. The International Diabetes Federation (IDF) estimates that there are 1.5 million adults with diabetes in Peru, a rapidly increasing patient population prone to peripheral vascular complications. The expanding focus on preventive and cardiovascular health and reforms in the healthcare system of Peru are also contributing to the increasing availability of vascular disease diagnosis and treatment.

Peripheral Vascular Devices Market (Historical, Current, Forecast)

• 2025 Peru Peripheral Vascular Devices Market Size: USD 17.5 Million
• Peru Peripheral Vascular Devices Market size, 2035 – USD 29 Million
• Peru Peripheral Vascular Devices CAGR 2026-2035 – 5.21%

Drivers

• Expansion of cardiovascular care and public health care services
• ~1.5 million adults living with diabetes, increased risk of peripheral vascular disease
• Increased prevalence of cardiovascular diseases, obesity and hypertension
• Growing hospital-based and outpatient vascular intervention programs

Restraints

• Specialized vascular treatment services are not easily accessible in rural areas
• High out-of-pocket cost for vascular procedures and long-term disease management
• lack of trained vascular specialists and interventionalists
• Dependence on imported peripheral vascular devices and technologies

Opportunities

• Growth of telehealth, digital platforms for vascular disease management
• Additional private investment in cardiovascular and vascular services
• Increased adoption of minimally invasive vascular intervention procedures
• Growing demand for cost-effective peripheral stents, angioplasty balloons and thrombectomy devices

Peripheral Vascular Devices Market Players

• Medtronic – 13.5%
• Boston Scientific – 12.5 %
• Abbott – 11.5%
• BD (Becton, Dickinson and Company) – 7.5%
• Terumo corporation – 6.5%
• Others

Peripheral Vascular Devices Market Recent developments

• In 2025, Boston Scientific Corporation expanded its peripheral intervention portfolio with innovative drug-coated technologies and vascular intervention platforms to improve outcomes for patients with peripheral artery disease (PAD). The company’s emphasis on minimally invasive therapies is consistent with the growing need for endovascular procedures that boost vessel patency rates and shorten recovery times.
• Shockwave Medical, Inc. said it will further expand its intravascular lithotripsy (IVL) technology to treat calcified peripheral artery disease lesions in 2024. Vascular specialists have increasingly adopted this technology because it can modify calcified plaque with limited vessel trauma. This technology has helped the trend toward advanced minimally invasive peripheral vascular interventions. Peripheral IVL Technology Shockwave Medical
• Major vascular device companies such as Medtronic plc, Abbott Laboratories and Terumo Corporation continued to invest in AI-based vascular imaging, procedural planning and digital health care integration in 2025. The technologies improve the precision of treatment, enabling personalized vascular management and refining clinical decision-making for complicated procedures in peripheral artery disease.
• The US regulatory environment for innovation in peripheral vascular technologies remained favourable in 2024, with several approvals and expanded indications for drug-coated balloons, peripheral stents, thrombectomy systems and atherectomy devices. These advances have improved access to minimally invasive treatment options for peripheral artery disease, chronic limb-threatening ischemia and other vascular disorders.
• There is a major trend of increasing adoption of next-generation drug-coated balloons and drug-eluting peripheral stents in North America, Europe and Asia-Pacific by 2025. These technologies are being used to reduce restenosis rates and improve long-term vessel patency and facilitate the transition to evidence-based endovascular therapies for the treatment of peripheral artery disease.
• 2024 – Vascular care providers further increased their use of advanced thrombectomy and mechanical clot removal systems for management of acute limb ischemia and thrombotic peripheral vascular conditions. The increasing preference for catheter-based interventions is in line with general health care trends for less invasive interventions and shorter hospital stays.
• In 2025, the use of integrated digital platforms for screening for peripheral vascular disease, monitoring patients and post-procedural follow-up continues to expand in healthcare systems and vascular centers. These efforts are increasing the efficiency of disease management and allowing earlier intervention in the high-risk populations, especially diabetes and cardiovascular disease patients. Resources for Peripheral Artery Disease from the American Heart Association Regulatory Landscape Analysis of Peripheral Vascular Devices Market (2025)
• Health Authority Approvals and Medical Devices Regulatory Frameworks: Peripheral vascular devices are medical devices and are subject to approval, clearance or certification by regulatory authorities, such as U.S. Food and Drug Administration, European Commission, Pharmaceuticals and Medical Devices Agency and other national health authorities. To get a product to market, such as peripheral stents, drug-coated balloons, atherectomy systems, thrombectomy devices, guidewires and vascular catheters, it must demonstrate it is safe, effective, biocompatible and works clinically. Regulatory pathways usually involve Premarket Approval (PMA), 510(k) clearance, CE Mark certification or country-specific approval processes.

Manufacturers shall provide preclinical testing and bench performance data, risk assessment and clinical evidence of the safety and effectiveness of the device. Devices used in the peripheral vasculature that are considered high risk, such as drug-eluting stents, drug-coated balloons, and atherectomy systems, typically require multicenter clinical trials to determine vessel patency, target lesion revascularization rates, and long-term patient outcomes before they are approved for use by regulatory agencies.

Quality Management Systems & Manufacturing Compliance:

Manufacturers of peripheral vascular devices are required to adhere to internationally recognized quality management standards such as International Organization for Standardization and regulatory quality system requirements such as FDA Quality System Regulation (QSR) and EU MDR provisions. These frameworks dictate device design, manufacturing controls, sterilization validation, risk management, traceability and post-market quality monitoring to ensure the product’s long-term performance and patient safety. After commercialization, regulatory authorities require manufacturers to have a post-market surveillance system, report adverse events, perform field safety corrective actions and provide periodic safety updates. According to the EU MDR and FDA Medical Device Reporting (MDR) frameworks, manufacturers are obligated to continuously monitor the performance of their devices in the real world, identify safety signals and take corrective actions as needed. There is an increasing emphasis on real-world evidence and long-term clinical follow-up for peripheral vascular interventions.

The use of AI-enabled imaging, digital procedural planning, remote monitoring, and connected medical devices are becoming more prevalent in peripheral vascular procedures, and regulators are raising demands for cybersecurity, software validation, data protection and interoperability. As connected vascular technologies develop, device manufacturers need to comply with digital health regulations to ensure device safety and protect patient health information.

Patent and IP Landscape of Peripheral Vascular Devices Market

Analysis of Patent Expiry

Importance: Enhances procedural efficiency, reduces fluoroscopy exposure and permits minimally invasive treatment of peripheral vascular disease.

A patent application has been published in the US for a catheter guidance platform that has the capability of performing AI-enhanced imaging analytics as well as real-time mapping of vessels to guide the catheter through complex peripheral vasculature.

March 2026 - Intelligent Catheter Navigation System (patent filing)

Importance: Emphasizes the growing adoption of AI-assisted decision support systems in vascular interventions, potentially enhancing procedural accuracy and personalised treatment strategies.

We developed a research-grade AI platform that integrates angiographic imaging, lesion characterization and procedural recommendations to assist clinicians in planning treatment for peripheral artery disease (PAD). The system uses machine learning algorithms to help with device selection and procedure optimization.

May 2026 – AI planning platform for peripheral interventions

Upcoming Innovations (2026 Developments)

The Peripheral Vascular Devices Market is driven by continuous innovation in drug-coated balloons (DCBs), drug-eluting stents (DES), atherectomy systems, thrombectomy devices, vascular imaging technologies, and intravascular lithotripsy (IVL) platforms. As early generation peripheral stent and balloon products’ patents have expired, manufacturers are focusing on next generation coatings, bioresorbable materials, AI-assisted imaging, vessel preparation and advanced catheter-based interventions to lock in their competitive differentiation and intellectual property position.

Significance: Enables the move to remote patient monitoring and value-based vascular care.

A new patent describes a system to monitor vascular health post-procedure, using wearable sensors and cloud analytics to identify early signs of restenosis or thrombosis following peripheral interventions.

January 2026 – Intelligent Vascular Monitoring Device with Remote Connectivity

2025 Development

Importance: Towards intelligent vascular implants with the ability to generate real-world clinical performance data.

A patent application recently filed detailed a platform for a peripheral stent that can incorporate sensing technologies to track blood flow dynamics and vessel healing post-implantation.

February 2025 – Smart peripheral stent with integrated monitoring

Importance: Supports the ongoing development of vessel preparation technologies and minimally invasive treatment options.

A patent application described improvements in intravascular lithotripsy catheter design including improved energy delivery systems to treat heavily calcified peripheral lesions.

May 2025 – Next Generation Intravascular Lithotripsy System (Patent Application)

Significance: It expands the competitive space in the treatment of peripheral artery disease and expands the scope of intellectual property protection of DCB technologies.

In one granted patent, a next-generation drug-coated balloon was described with improved drug-transfer coatings to enhance absorption into the vessel wall and reduce rates of restenosis.

July 2025 – Patent Issued for Next-gen Drug-Coated Balloon Technology

Importance: Allows improved selection of therapy for atherectomy, intravascular lithotripsy, and drug coated balloon procedures.

Scientists have created an artificial intelligence (AI)-based imaging analysis system that can identify plaque morphology and calcification severity from angiographic and intravascular imaging datasets.

September 2025 – Platform for AI-assisted peripheral plaque characterization

2024 Developments:

Importance: Addresses the increasing demand for less invasive treatment options for thrombotic peripheral vascular disease.

A patent showed a second generation thrombectomy catheter that claimed to work with greater efficiency to extract the clot and with less trauma to the vessel in the treatment of acute limb ischemia.

November 2024 – Breakthroughs in Mechanical Thrombectomy for Peripheral Arterial Occlusions

The present invention relates to a device for measuring the quantity of a substance in a sample, and more specifically to a device for measuring the concentration of a substance in a liquid sample by using the phenomenon of fluorescence.

Significance: Takes innovation beyond conventional metallic stents and potentially decreases long term implant related morbidity.

R&D teams and device makers have developed bioresorbable scaffold technologies to provide temporary vessel support, and then gradually dissolve after healing.

August 2024 – Bioresorbable Peripheral Vascular Scaffold Technology

Significance: Enhances diagnostic accuracy and enables procedure planning for complex peripheral interventions.

The newly patented software solution uses deep learning algorithms to improve image quality and lesion detection in peripheral vascular procedures.

April 2024 – AI-Enabled Platform to Enhance Vascular Imaging

Patents focused on novel polymer and drug delivery technologies to enhance long-term patency and reduce restenosis after peripheral artery procedures.

January 2024 – Progress in Drug Eluting Peripheral Stent Coatings

Significance: Demonstrates ongoing investment in next generation drug eluting vascular technologies.

Peripheral Vascular Devices Market Segmentation

By Type of Product:

• Balloons for Angioplasty
• Drug Coated Balloons (DCB’s)
• Stent periferico
• Athéctomie devices
• Devices for thrombectomy
• Guide wires;
• Catheters
• IVC (Inferior Vena Cava) Filters
• Hemodynamic flow altering devices
• Other

By Application:

• Peripheral arterial disease (PAD)
• Deep Venous Thrombosis (DVT)
• Chronic Venous Insufficiency
• Pulmonary Embolism
• Aneurisms
• Critical Limb Ischemia
• Management of Arteriovenous Fistulaa
• Other

By User Type:

• Health care facilities
• Ambulatory Surgical centres (ASC’s)
• Vascular Specialty Clinics
• Cath Labs
• Imaging Centres
• Others. By Technology:
• Conventional Endovascular Devices
• Technologies coated with drugs
• Drug release technologies
• Intra Vascular Imaging Technologies
• Technologies for Mechanical Thrombectomy
• Other